These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35772388)

  • 1. Metabolic Changes across Tertiles of Delta Changes in Height SDS during Growth Hormone Therapy in Children with Growth Hormone Deficiency.
    Giannini C; Mastromauro C; Polidori N; Chiarelli F; Mohn A
    Horm Res Paediatr; 2022; 95(5):415-422. PubMed ID: 35772388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The associations between the growth hormone/insulin-like growth factor-1 axis, adiponectin, resistin and metabolic profile in children with growth hormone deficiency before and during growth hormone treatment.
    Witkowska-Sędek E; Rumińska M; Stelmaszczyk-Emmel A; Majcher A; Pyrżak B
    Acta Biochim Pol; 2018; 65(2):333-340. PubMed ID: 29913483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
    Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
    J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency.
    Ciresi A; Amato MC; Criscimanna A; Mattina A; Vetro C; Galluzzo A; D'Acquisto G; Giordano C
    Eur J Endocrinol; 2007 Mar; 156(3):353-60. PubMed ID: 17322495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth Responses During 3 Years of Growth Hormone Treatment in Children and Adolescents With Growth Hormone Deficiency: Comparison Between Idiopathic, Organic and Isolated Growth Hormone Deficiency, and Multiple Pituitary Hormone Deficiency.
    Lim HH; Kim YM; Lee GM; Yu J; Han HS; Yu J
    J Korean Med Sci; 2022 Mar; 37(11):e90. PubMed ID: 35315601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary IGF-I deficiency as a prognostic factor of growth hormone (GH) therapy effectiveness in children with isolated, non-acquired GH deficiency.
    Smyczyńska J; Stawerska R; Hilczer M; Lewiński A
    Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):209-14. PubMed ID: 25607339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender-specific soluble α-klotho levels as marker of GH deficiency in children: a case-control study.
    Guarnotta V; Pizzolanti G; Petrancosta R; Radellini S; Baiamonte C; Giordano C
    J Endocrinol Invest; 2022 Jun; 45(6):1247-1254. PubMed ID: 35279809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the growth response of children with growth hormone deficiency according to the peak growth hormone levels in provocation tests.
    Donbaloğlu Z; Singin B; Acar S; Bedel A; Barsal Çetiner E; Aydın Behram B; Parlak M; Tuhan H
    Arch Pediatr; 2023 Nov; 30(8):573-579. PubMed ID: 37802668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of growth hormone (GH) therapy withdrawal on glucose metabolism in not confirmed GH deficient adolescents at final height.
    Prodam F; Savastio S; Genoni G; Babu D; Giordano M; Ricotti R; Aimaretti G; Bona G; Bellone S
    PLoS One; 2014; 9(1):e87157. PubMed ID: 24498035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
    Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the underlying etiology of growth hormone deficiency on serum IGF-I SDS levels during GH treatment in children.
    Léger J; Mohamed D; Dos Santos S; Ben Azoun M; Zénaty D; Simon D; Paulsen A; Martinerie L; Chevenne D; Alberti C; Carel JC; Guilmin-Crepon S
    Eur J Endocrinol; 2017 Sep; 177(3):267-276. PubMed ID: 28760908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of growth hormone therapy on Taiwanese children with growth hormone deficiency.
    Huang YH; Wai YY; Van YH; Lo FS
    J Formos Med Assoc; 2012 Jul; 111(7):355-63. PubMed ID: 22817812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
    Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
    Wacharasindhu S; Supornsilchai V; Aroonparkmongkol S; Srivuthana S
    J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth Hormone (GH) Therapy During the Transition Period: Should We Think About Early Retesting in Patients with Idiopathic and Isolated GH Deficiency?
    Penta L; Cofini M; Lucchetti L; Zenzeri L; Leonardi A; Lanciotti L; Galeazzi D; Verrotti A; Esposito S
    Int J Environ Res Public Health; 2019 Jan; 16(3):. PubMed ID: 30678118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum adiponectin levels in adolescents and young adults with growth hormone deficiency.
    Oswiecimska JM; Roczniak W; Roczniak RG; Malczyk Z; Chyra M; Mazur B; Ziora KT
    Neuro Endocrinol Lett; 2017 May; 38(2):107-116. PubMed ID: 28650604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth response and metabolic effects of growth hormone therapy in appropriate-for-gestational-age growth hormonedeficient children in relation to birth size and gestational age: A preliminary study.
    Witkowska-Sędek E; Stelmaszczyk-Emmel A; Kucharska A; Rumińska M; Majcher A; Pyrżak B
    Acta Biochim Pol; 2020 Nov; 67(4):509-514. PubMed ID: 33242242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.